Novo Nordisk Wins Modern Insulin Market Share, Berlingske Says

Novo Nordisk A/S has increased its share of the global market for modern insulin to 40.5 percent in 2009 from 38 percent in 2008, Copenhagen-based newspaper Berlingske Tidende reported today citing its own research.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.